Brand name
Oseni, the original
We didn’t find a savings card or cash price from Oseni’s maker. Ask the pharmacy for Oseni’s cash price. With insurance, ask what your plan charges.
Generic name: alogliptin benzoate and pioglitazone
Used for: Type 2 diabetes
Ask for the cash price
Authorized generic
Oseni itself, without the brand name. It usually costs less than Oseni.
None is sold. The authorized generic is the only generic.
Oseni, the original
We didn’t find a savings card or cash price from Oseni’s maker. Ask the pharmacy for Oseni’s cash price. With insurance, ask what your plan charges.
The same medicine as Oseni, without the brand name
The same medicine as Oseni, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.
alogliptin benzoate and pioglitazone
Pick your strength
Give the pharmacy this NDC
What to say at the pharmacy
“Before you fill my Oseni, can you tell me what I’d pay for the brand, for the authorized generic from Padagis Israel Pharmaceuticals (NDC )?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Source: FDA, updated November 16, 2026
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
12.5 mg / 30 mg tablet
Same active and inactive ingredients as Oseni.
Active: alogliptin benzoate 12.5 mg · pioglitazone hydrochloride 30 mg
Inactive, on both labels:
25 mg / 15 mg tablet
Same active and inactive ingredients as Oseni.
Active: alogliptin benzoate 25 mg · pioglitazone hydrochloride 15 mg
Inactive, on both labels:
25 mg / 30 mg tablet
Same active and inactive ingredients as Oseni.
Active: alogliptin benzoate 25 mg · pioglitazone hydrochloride 30 mg
Inactive, on both labels:
25 mg / 45 mg tablet
Same active and inactive ingredients as Oseni.
Active: alogliptin benzoate 25 mg · pioglitazone hydrochloride 45 mg
Inactive, on both labels:
None is sold. The authorized generic is the only generic.
OSENI is a combination of alogliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use: OSENI is not recommended for use in patients with type 1 diabetes mellitus.
Source: the FDA label for Oseni (Takeda Pharmaceuticals America, Inc.), February 28, 2025. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/oseni/